chlorpropamide has been researched along with Parkinson Disease in 3 studies
Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Majid, N | 1 |
| Siddiqi, MK | 1 |
| Hassan, MN | 1 |
| Malik, S | 1 |
| Khan, S | 1 |
| Khan, RH | 1 |
| BARRINGTON, PC | 1 |
| Ahmed, I | 1 |
| Ahmad, B | 1 |
| Hussain, MF | 1 |
1 trial available for chlorpropamide and Parkinson Disease
| Article | Year |
|---|---|
The use of chlorpropamide in the treatment of Parkinsonism.
Topics: Adult; Aged; Chlorpropamide; Female; Humans; Male; Middle Aged; Parkinson Disease | 1968 |
2 other studies available for chlorpropamide and Parkinson Disease
| Article | Year |
|---|---|
Inhibition of primary and secondary nucleation alongwith disruption of amyloid fibrils and alleviation of associated cytotoxicity: A biophysical insight of a novel property of Chlorpropamide (an anti-diabetic drug).
Topics: Amyloid; Amyloidogenic Proteins; Amyloidosis; Chlorpropamide; Humans; Parkinson Disease | 2023 |
CHLORPROPAMIDE IN PARKINSON'S DISEASE.
Topics: Biomedical Research; Chlorpropamide; Drug Therapy; Humans; Parkinson Disease; Parkinsonian Disorders | 1964 |